ReproCELL, Inc. (JASDAQ:4978) agreed to acquire 85.2% stake in Reinnervate Limited from Northstar Ventures, Parkwalk UK Technology Fund II, a fund managed by Parkwalk Advisors Ltd, Jules Green, Simon Constantine, Simon Pilcher and Durham University for £2.5 million on May 26, 2014. ReproCELL will acquire 0.26 million shares of Reinnervate as a part of this transaction. In a related transaction, ReproCELL, Inc. agreed to acquire 67.6% stake in BioServe Biotechnologies, Ltd. from Rama Modali and Ventureast Trustee Company Pvt Ltd. for $1.7 million (£1 million) on May 26, 2014. The transaction is expected to close on June 30, 2014. The conversions have been made using oanda.com as on May 26, 2014.

ReproCELL, Inc. (JASDAQ:4978) completed the acquisition of 85.2% stake in Reinnervate Limited from Northstar Ventures, Parkwalk UK Technology Fund II, a fund managed by Parkwalk Advisors Ltd, Jules Green, Simon Constantine, Simon Pilcher and Durham University on August 4, 2014.